Penumbra (PEN) Shareholder's Equity Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.89% |
| Dec 31, 2025 | 12.64% |
| Sep 30, 2025 | 11.74% |
| Jun 30, 2025 | 10.08% |
| Mar 31, 2025 | 8.13% |
| Dec 31, 2024 | 6.46% |
| Sep 30, 2024 | 17.28% |
| Jun 30, 2024 | 19.92% |
| Mar 31, 2024 | 22.77% |
| Dec 31, 2023 | 22.73% |
| Sep 30, 2023 | 21.23% |
| Jun 30, 2023 | 19.62% |
| Mar 31, 2023 | 28.03% |
| Dec 31, 2022 | 27.18% |
| Sep 30, 2022 | 27.76% |
| Jun 30, 2022 | 28.78% |
| Mar 31, 2022 | 30.00% |
| Dec 31, 2021 | 31.20% |
| Sep 30, 2021 | 18.71% |
| Jun 30, 2021 | 16.56% |
| Mar 31, 2021 | 16.17% |
| Dec 31, 2020 | 16.79% |
| Sep 30, 2020 | 3,283.43% |
| Jun 30, 2020 | 2,440.72% |
| Mar 31, 2020 | 2,307.17% |
| Dec 31, 2019 | 22.13% |
| Sep 30, 2019 | 1,624.81% |
| Jun 30, 2019 | 1,201.53% |
| Mar 31, 2019 | 723.05% |
| Dec 31, 2018 | 22.02% |
| Sep 30, 2018 | 545.10% |
| Jun 30, 2018 | 602.61% |
| Mar 31, 2018 | 520.32% |
| Dec 31, 2017 | 225.13% |